Ulcerative colitis is a form of inflammatory bowel disease (IBD), a chronic disease for which there is currently no known cure. The primary sign of the condition is inflammation of the colon and ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness of vedolizumab (Entyvio) versus ustekinumab (Stelara) and of each biologic ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

Around 2600 people with untreated multiple myeloma and over 23,000 people with ulcerative colitis in England are set to benefit from new treatment options following final draft guidance from the ...